Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.

about

Steroid hormone profiling in obese and nonobese women with polycystic ovary syndrome.

P2860

Q42621044-C4119871-1EEC-4BE5-8323-7851CDFA2F9A

P2860

Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.

Item

http://www.wikidata.org/entity/Q54148180

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Performance of mass spectromet ...... of polycystic ovary syndrome.

@en

Performance of mass spectromet ...... of polycystic ovary syndrome.

@nl

type

Item

label

Performance of mass spectromet ...... of polycystic ovary syndrome.

@en

Performance of mass spectromet ...... of polycystic ovary syndrome.

@nl

prefLabel

Performance of mass spectromet ...... of polycystic ovary syndrome.

@en

Performance of mass spectromet ...... of polycystic ovary syndrome.

@nl

P1476

Performance of mass spectromet ...... of polycystic ovary syndrome.

@en

P2093

D J Handelsman

http://www.w3.org/2001/XMLSchema#string

R Desai

http://www.w3.org/2001/XMLSchema#string

R J Norman

http://www.w3.org/2001/XMLSchema#string

P2860

Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.

Development and validation of a sensitive liquid chromatography-tandem mass spectrometry assay to simultaneously measure androgens and estrogens in serum without derivatization.

Measurement of Estradiol in Human Serum by LC-MS/MS Using a Novel Estrogen-Specific Derivatization Reagent.

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria

Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women.

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.

Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.

Ultrasound assessment of the polycystic ovary: international consensus definitions.

P304

418-422

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/DEW328

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lisa J Moran

Helena J. Teede

P577

2016-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27999117

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.

about

P2860

P2860

Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921